Effect of plaque brachytherapy dose and dose rate on risk for disease-related mortality in 1238 patients with choroidal melanoma.
CONCLUSION: There are no increased hazards for choroidal melanoma-related mortality after brachytherapy with decreasing doses between 108.6 and 73.0 Gy, or with decreasing dose rates between 2.8 and 0.5 Gy/hour.
PMID: 32430342 [PubMed - as supplied by publisher]
Source: The British Journal of Ophthalmology - Category: Opthalmology Authors: Filì M, Trocme E, Herrspiegel C, Seregard S, Stålhammar G Tags: Br J Ophthalmol Source Type: research
More News: Brachytherapy | Eye Cancers | Iodine | Melanoma | Opthalmology | Skin Cancer | UK Health | Uveal Melanoma